HighTower Advisors
ABVX icon

HighTower Advisors’s Abivax ABVX Stock Holding History

HighTower Advisors’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Buy
+2,003
New +$227K ﹤0.01% 3308
2025
Q1 		– Sell
-10,000
Closed -$73.2K – 3726
2024
Q4 		$73.2K Hold
10,000
– – ﹤0.01% 3420
2024
Q3 		$115K Hold
10,000
– – ﹤0.01% 3282
2024
Q2 		$132K Hold
10,000
– – ﹤0.01% 3138
2024
Q1 		$143K Hold
10,000
– – ﹤0.01% 3068
2023
Q4 		$107K Buy
+10,000
New +$102K ﹤0.01% 3182

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighTower Advisors's ABVX Position: Q2 2026 in Review

HighTower Advisors opened a new position in Abivax (ABVX) in Q2 2026: 2,003 shares worth $267K. The stake represents ﹤0.01% of the portfolio and ranks #3308 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in ABVX as recently as Q4 2024.

HighTower Advisors first reported a position in ABVX in Q4 2023 and has held it in 6 quarters since. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • HighTower Advisors held 2,003 shares of Abivax worth $267K as of Q2 2026.
  • Abivax was a new HighTower Advisors position in Q2 2026.
  • Abivax made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3308 holding.
  • HighTower Advisors first reported a position in Abivax in Q4 2023 and has held it in 6 quarters since.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.